Main > A1. CORP. INDEX. An-Az > AsuraGen/P C2
AsuraGen/P C2's subsections
2007. 10.29.2007. Xenomics
2010. 07.13.2010. Onco.>CML
2010. 09.01.2010. Onco.>Colon C.
2011. 03.23.2011. FXS Diagnostics
2012. 02.17.2012. Onco.>PDAC
2012. 03.22.2012. FDA Clears
2012. 03.30.2012. Awarded $6.8 M
2013. 01.07.2013. CEO
2013. 03.21.2013. FXS Prognostics
2013. 05.30.2013. Seq. Services
2016. 07.25. Onco.>CML
2018. 09.05. Onco.>CE Mark &
2020. 02.24. FXS Diagnostics
2021. 03.03. Acq. By Bio Techne
Web-Site
AsuraGen/P C2's products
This section has no products